Edition:
India

Bio Rad Laboratories Inc (BIO.N)

BIO.N on New York Stock Exchange

255.49USD
17 Nov 2017
Change (% chg)

$-0.77 (-0.30%)
Prev Close
$256.26
Open
$255.84
Day's High
$256.59
Day's Low
$254.69
Volume
36,738
Avg. Vol
35,973
52-wk High
$268.40
52-wk Low
$169.64

Chart for

About

Bio-Rad Laboratories, Inc. (Bio-Rad) is a manufacturer and distributor of its life science research and clinical diagnostics products. The Company operates through two segments: Life Science and Clinical Diagnostics. It manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a... (more)

Overall

Beta: 0.89
Market Cap(Mil.): $6,701.81
Shares Outstanding(Mil.): 29.58
Dividend: --
Yield (%): --

Financials

BRIEF-Bio Rad Laboratories reports Q3 earnings per share $0.91

* Bio Rad Laboratories Inc reports third-quarter 2017 financial results

03 Nov 2017

BRIEF-U.S. ITC to probe certain 10X Genomics devices after Bio-Rad complaint

* U.S. U.S. International Trade Commission says it will investigate certain microfluidic devices by 10x Genomics Inc after complaint by Bio-rad Laboratories Inc and Lawrence Livermore National Security LLC. Source text for Eikon: Further company coverage: (Reporting By Susan Heavey)

31 Aug 2017

BRIEF-Bio-Rad reports Q2 earnings per share $0.17

* Q2 earnings per share view $0.56 -- Thomson Reuters I/B/E/S

04 Aug 2017

BRIEF-Virbac signs a research agreement with Bio-Gene

* VIRBAC SA - VIRBAC SIGNS A RESEARCH AGREEMENT WITH BIO-GENE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

16 Jun 2017

BRIEF-Bio Rad Laboratories receives FDA clearance for Bioplex 2200 syphilis total & RPR assay​

* Bio Rad Laboratories Inc - ‍has received U.S. Food and Drug Administration clearance for its Bioplex 2200 syphilis total & RPR assay​ Source text for Eikon: Further company coverage:

12 Jun 2017

BRIEF-Bio-Rad introduces enhanced options with its IH-COM data management software

* Bio-Rad introduces enhanced options with its IH-COM data management software for managing patient results with the IH-1000 system Source text for Eikon: Further company coverage:

25 May 2017

BRIEF-Amicogen buys 9.1 pct stake in Bio-Works Technologies AB

* Says it has acquired 895,000 shares in Bio-Works Technologies AB, and is holding 9.1 percent stake in the co, from 0 percent stake

18 May 2017

Earnings vs. Estimates